BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30397132)

  • 1. Inhibition of HDAC3 reverses Alzheimer's disease-related pathologies in vitro and in the 3xTg-AD mouse model.
    Janczura KJ; Volmar CH; Sartor GC; Rao SJ; Ricciardi NR; Lambert G; Brothers SP; Wahlestedt C
    Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11148-E11157. PubMed ID: 30397132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.
    Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y
    Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase-3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer's disease models.
    Davis N; Taylor B; Abelleira-Hervas L; Karimian-Marnani N; Aleksynas R; Syed N; Di Giovanni S; Palmisano I; Sastre M
    FASEB J; 2024 May; 38(10):e23659. PubMed ID: 38733301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer's disease genes and improving memory.
    Volmar CH; Salah-Uddin H; Janczura KJ; Halley P; Lambert G; Wodrich A; Manoah S; Patel NH; Sartor GC; Mehta N; Miles NTH; Desse S; Dorcius D; Cameron MD; Brothers SP; Wahlestedt C
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):E9135-E9144. PubMed ID: 29073110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivirus-Mediated HDAC3 Inhibition Attenuates Oxidative Stress in APPswe/PS1dE9 Mice.
    Yu L; Liu Y; Jin Y; Cao X; Chen J; Jin J; Gu Y; Bao X; Ren Z; Xu Y; Zhu X
    J Alzheimers Dis; 2018; 61(4):1411-1424. PubMed ID: 29376873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
    Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
    J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease.
    Sung YM; Lee T; Yoon H; DiBattista AM; Song JM; Sohn Y; Moffat EI; Turner RS; Jung M; Kim J; Hoe HS
    Exp Neurol; 2013 Jan; 239():192-201. PubMed ID: 23063601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease.
    Yang W; Chauhan A; Wegiel J; Kuchna I; Gu F; Chauhan V
    Curr Alzheimer Res; 2014; 11(10):1002-11. PubMed ID: 25387339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader Proteins.
    Sartor GC; Malvezzi AM; Kumar A; Andrade NS; Wiedner HJ; Vilca SJ; Janczura KJ; Bagheri A; Al-Ali H; Powell SK; Brown PT; Volmar CH; Foster TC; Zeier Z; Wahlestedt C
    J Neurosci; 2019 Jan; 39(4):612-626. PubMed ID: 30504275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation.
    Himeno E; Ohyagi Y; Ma L; Nakamura N; Miyoshi K; Sakae N; Motomura K; Soejima N; Yamasaki R; Hashimoto T; Tabira T; LaFerla FM; Kira J
    Ann Neurol; 2011 Feb; 69(2):248-56. PubMed ID: 21387370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
    Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
    Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease.
    Modi KK; Jana A; Ghosh S; Watson R; Pahan K
    PLoS One; 2014; 9(8):e103606. PubMed ID: 25089827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Targeting of Class I HDAC Reduces Microglial Inflammation in the Entorhinal Cortex of Young APP/PS1 Mice.
    Wang C; Shen D; Hu Y; Chen J; Liu J; Huang Y; Yu X; Chu H; Zhang C; Yin L; Liu Y; Ma H
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3×Tg-AD mice.
    Minami SS; Clifford TG; Hoe HS; Matsuoka Y; Rebeck GW
    Neurobiol Aging; 2012 Apr; 33(4):825.e15-24. PubMed ID: 21741124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Histone Deacetylase 3 Restores Amyloid-β Oligomer-Induced Plasticity Deficit in Hippocampal CA1 Pyramidal Neurons.
    Krishna K; Behnisch T; Sajikumar S
    J Alzheimers Dis; 2016; 51(3):783-91. PubMed ID: 26890755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease.
    Walker MP; LaFerla FM; Oddo SS; Brewer GJ
    Age (Dordr); 2013 Jun; 35(3):519-31. PubMed ID: 22237558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.